An international team of researchers has identified a direct molecular link between meat and dairy diets and the development of antibodies in the blood that increase the chances of developing cancer. This connection may explain ...
Oct 22, 2020
3
2499
An international team of researchers has used mRNA technology to develop an influenza vaccine that targets four proteins that tend to change little across viral strains. In their paper published in Proceedings of the National ...
New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has shown that a longer interval between primary COVID-19 vaccine doses ...
Apr 22, 2022
0
45
(Medical Xpress)—While our immune system protects us from myriad bacterial and viral attacks by producing antigen-specific antibodies, this process can sometimes go awry. In such cases, the antibodies target cells and tissues ...
No story in biology is more intriguing than the one involving B cells and the intricate processes that result in antibody production—it's a story about mathematics, a tale of genetics and a saga of how vast armies of tiny ...
Myocarditis, a condition in which the heart muscle becomes inflamed, is a rare complication that can occur after mRNA COVID vaccination. It's estimated that roughly 18 cases occur in every 1 million vaccine doses administered, ...
Jan 4, 2023
0
34
Over the past year, researchers at the California Institute of Technology, and around the world, have been studying a group of potent antibodies that have the ability to neutralize HIV in the lab; their hope is that they ...
Nov 30, 2011
0
0
(Medical Xpress) -- A vaccine delivered to the skin using a microneedle patch gives better protection against the H1N1 influenza virus than a vaccine delivered through subcutaneous or intramuscular injection, researchers ...
Jul 12, 2011
1
0
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment—which depletes the B cells that contribute to the MS attacks—are able to mount robust T-cell responses to the mRNA COVID-19 ...
Sep 15, 2021
0
176
Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use. And with minor changes, Northwestern University researchers ...
Mar 22, 2022
0
128
